Physiologic benefits of pulsatile perfusion during mechanical circulatory support for the treatment of acute and chronic heart failure in adults.

A growing population experiencing heart failure (100,000 patients/year), combined with a shortage of donor organs (less than 2200 hearts/year), has led to increased and expanded use of mechanical circulatory support (MCS) devices. MCS devices have successfully improved clinical outcomes, which are comparable with heart transplantation and result in better 1-year survival than optimal medical management therapies. The quality of perfusion provided during MCS therapy may play an important role in patient outcomes. Despite demonstrated physiologic benefits of pulsatile perfusion, continued use or development of pulsatile MCS devices has been widely abandoned in favor of continuous flow pumps owing to the large size and adverse risks events in the former class, which pose issues of thrombogenic surfaces, percutaneous lead infection, and durability. Next-generation MCS device development should ideally implement designs that offer the benefits of rotary pump technology while providing the physiologic benefits of pulsatile end-organ perfusion.

[1]  R. Thiagarajan,et al.  Cardiac extracorporeal life support: state of the art in 2007 , 2007, Cardiology in the Young.

[2]  M. Loebe,et al.  Cellular and hemodynamics responses of failing myocardium to continuous flow mechanical circulatory support using the DeBakey-Noon left ventricular assist device: a comparative analysis with pulsatile-type devices. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  Kevin Bourque,et al.  In vivo assessment of a rotary left ventricular assist device-induced artificial pulse in the proximal and distal aorta. , 2006, Artificial organs.

[4]  A. Cribier,et al.  Mechanical circulatory assistance in myocardial infarction with refractory cardiogenic shock: clinical experience in 10 patients at a teaching hospital in Rouen. , 2008, Archives of cardiovascular diseases.

[5]  Peter Kleine,et al.  Venoarterial extracorporeal membrane oxygenation for treatment of cardiogenic shock: clinical experiences in 45 adult patients. , 2008, The Journal of thoracic and cardiovascular surgery.

[6]  O H Frazier,et al.  Surgery for Acquired Cardiovascular Disease Initial experience with the AbioCor Implantable Replacement Heart System , 2004 .

[7]  M. Stone.  Current Status of Mechanical Circulatory Assistance , 2007, Seminars in cardiothoracic and vascular anesthesia.

[8]  A. Ündar.  Benefits of pulsatile flow during and after cardiopulmonary bypass procedures. , 2005 .

[9]  G. Tenderich,et al.  Implantation of CardioWest total artificial heart for irreversible acute myocardial infarction shock. , 2007, The heart surgery forum.

[10]  P. Graham,et al.  The Role of Extra Corporeal Membrane Oxygenation for Treatment of the Adult Respiratory Distress Syndrome: Review and Quantitative Analysis , 2008, Anaesthesia and intensive care.

[11]  J. Cleveland,et al.  Mechanical support in acute and chronic heart failure , 2008, Current cardiology reports.

[12]  A. Undar,et al.  Evaluation of membrane oxygenators and reservoirs in terms of capturing gaseous microemboli and pressure drops. , 2009, Artificial organs.

[13]  L. Miller,et al.  Destination therapy: current results and future promise. , 2008, Seminars in thoracic and cardiovascular surgery.

[14]  Pascal Leprince,et al.  Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock* , 2008, Critical care medicine.

[15]  Gerson Rosenberg,et al.  Major factors in the controversy of pulsatile versus nonpulsatile flow during acute and chronic cardiac support. , 2005, ASAIO journal.

[16]  William A. Smith,et al.  Reduced pulsatility induces periarteritis in kidney: role of the local renin-angiotensin system. , 2008, The Journal of thoracic and cardiovascular surgery.

[17]  Roland Hetzer,et al.  Does total implantability reduce infection with the use of a left ventricular assist device? The LionHeart experience in Europe. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[18]  J. Connell,et al.  Neurologic events with a totally implantable left ventricular assist device: European LionHeart Clinical Utility Baseline Study (CUBS). , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[19]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.

[20]  Nicola J Cooper,et al.  Methods of data collection and analysis for the economic evaluation alongside a national, multi-centre trial in the UK: Conventional ventilation or ECMO for Severe Adult Respiratory Failure (CESAR) , 2008, BMC health services research.

[21]  Patrick Segers,et al.  Hemodynamic Modes of Ventricular Assist with a Rotary Blood Pump: Continuous, Pulsatile, and Failure , 2005, ASAIO journal.

[22]  B. Griffith,et al.  Clinical outcomes are similar in pulsatile and nonpulsatile left ventricular assist device recipients. , 2007, The Annals of thoracic surgery.

[23]  S. Garcia,et al.  Effects of pulsatile- and continuous-flow left ventricular assist devices on left ventricular unloading. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[24]  George M Pantalos,et al.  Vascular pulsatility in patients with a pulsatile- or continuous-flow ventricular assist device. , 2007, The Journal of thoracic and cardiovascular surgery.

[25]  Marvin J Slepian,et al.  Cardiac replacement with a total artificial heart as a bridge to transplantation. , 2004, The New England journal of medicine.

[26]  Y Sezai,et al.  The role of pulsatility in end-organ microcirculation after cardiogenic shock. , 1996, ASAIO journal.

[27]  C. Yancy,et al.  Pharmacologic therapies across the continuum of left ventricular dysfunction. , 2008, The American journal of cardiology.

[28]  H. Scheld,et al.  Left ventricular pressure and volume unloading during pulsatile versus nonpulsatile left ventricular assist device support. , 2004, The Annals of thoracic surgery.

[29]  A. Ündar,et al.  Review Article: Comparison of perfusion modes on microcirculation during acute and chronic cardiac support: is there a difference? , 2007, Perfusion.

[30]  Michiel Morshuis,et al.  Preliminary experience with the LionHeart left ventricular assist device in patients with end-stage heart failure. , 2003, The Annals of thoracic surgery.

[31]  Tomoyuki Yambe,et al.  Acute and chronic consequences of non-pulsatile blood flow pattern in long-term total artificial heart experiment. , 2007, Pathophysiology : the official journal of the International Society for Pathophysiology.

[32]  Craig H Selzman,et al.  Current status of the total artificial heart. , 2006, American heart journal.

[33]  M. Oz,et al.  Current Options for Mechanical Heart Technology , 2001, Journal of cardiac surgery.

[34]  C. Zapanta,et al.  Performance characterization of a rotary centrifugal left ventricular assist device with magnetic suspension. , 2008, Artificial organs.

[35]  G. Peek,et al.  Traumatic lung injury treated by extracorporeal membrane oxygenation (ECMO). , 2006, Injury.

[36]  R. Körfer,et al.  Altered levels of mRNA of apoptosis-mediating genes after mid-term mechanical ventricular support in dilative cardiomyopathy--first results of the Halle Assist Induced Recovery Study (HAIR). , 1999, The Thoracic and cardiovascular surgeon.

[37]  G. Rosenberg,et al.  Part 2: Principles of Research on Pulsatile and Nonpulsatile Perfusion , 2005 .

[38]  F. Pagani,et al.  Hemodynamic and Exercise Performance With Pulsatile and Continuous-Flow Left Ventricular Assist Devices , 2007, Circulation.

[39]  I. Saito,et al.  Microcirculation of the Bulbar Conjunctiva in the Goat Implanted with a Total Artificial Heart: Effects of Pulsatile and Nonpulsatile Flow , 2004, ASAIO journal.

[40]  R. Graaff,et al.  Pressure drop, shear stress, and activation of leukocytes during cardiopulmonary bypass: a comparison between hollow fiber and flat sheet membrane oxygenators. , 2000, Artificial organs.

[41]  R. Hetzer,et al.  Experience with over 1000 Implanted Ventricular Assist Devices , 2008, Journal of cardiac surgery.

[42]  A. Undar,et al.  Part 1: principles of research on pulsatile and nonpulsatile perfusion during chronic support. , 2005, ASAIO journal.

[43]  K. Kamohara,et al.  Phasic coronary blood flow pattern during a continuous flow left ventricular assist support. , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[44]  Tadahiko Shinshi,et al.  Third-generation blood pumps with mechanical noncontact magnetic bearings. , 2006, Artificial organs.